Pharmabiz13h
Insulet Corporation’s RADIANT study shows glycaemic improvements with Omnipod 5 automated insulin delivery system
Insulet Corporation’s RADIANT study shows glycaemic improvements with Omnipod 5 automated insulin delivery system: Action, Massachusetts Friday, March 21, 2025, 18:00 Hrs [IST] ...
Pharmabiz14h
Dhanwantari College of Pharmacy views career guidance as key to shape future of students
Dhanwantari College of Pharmacy views career guidance as key to shape future of students: Our Bureau, Bengaluru Friday, March 21, 2025, 17:30 Hrs [IST] Dhanwantari College of Phar ...
Pharmabiz14h
MMS Holdings’ REMS-focused technology bolsters full-service risk evaluation and mitigation strategy solutions
MMS Holdings’ REMS-focused technology bolsters full-service risk evaluation and mitigation strategy solutions: Canton, Michigan Friday, March 21, 2025, 17:00 Hrs [IST] MMS Holdi ...
Pharmabiz15h
Karnataka govt says KWIN City presents investment opportunities for dermatology & cosmetic treatment sectors
Karnataka govt says KWIN City presents investment opportunities for dermatology & cosmetic treatment sectors: Our Bureau, Bengaluru Friday, March 21, 2025, 16:45 Hrs [IST] Karnata ...
Pharmabiz15h
Rhythm Pharma gets orphan drug designation for its setmelanotide to treat hypothalamic obesity in Japan
Rhythm Pharma gets orphan drug designation for its setmelanotide to treat hypothalamic obesity in Japan: Boston Friday, March 21, 2025, 16:00 Hrs [IST] Rhythm Pharmaceuticals, Inc ...
Pharmabiz16h
Bioxytran inks non-disclosure agreement with University of Georgia to evaluate Galectin antagonists for bird flu treatment in chickens
Bioxytran inks non-disclosure agreement with University of Georgia to evaluate Galectin antagonists for bird flu treatment in chickens: Boston Friday, March 21, 2025, 15:00 Hrs [I ...
Pharmabiz17h
Prashanthi Balamandira Trust goes public on India’s NSE Social Stock Exchange Issue to raise Rs. 18 crore
Prashanthi Balamandira Trust goes public on India’s NSE Social Stock Exchange Issue to raise Rs. 18 crore: Our Bureau, Bengaluru Friday, March 21, 2025, 14:15 Hrs [IST] Karnatak ...
Pharmabiz17h
MAIA Biotechnology receives USAN Council approval for “ateganosine” as nonproprietary name for anticancer agent THIO
MAIA Biotechnology receives USAN Council approval for “ateganosine” as nonproprietary name for anticancer agent THIO: Chicago Friday, March 21, 2025, 14:00 Hrs [IST] MAIA Biot ...
Pharmabiz18h
Teknova & Pluristyx introduce proprietary PluriFreeze cryopreservation system to accelerate the development of cell therapies
Teknova & Pluristyx introduce proprietary PluriFreeze cryopreservation system to accelerate the development of cell therapies: Hollister, California Friday, March 21, 2025, 13:00 ...
Pharmabiz19h
Alvotech acquires Xbrane’s R&D operations in Sweden and further affirms its global leadership position in biosimilars development and production
Reykjavik, Iceland Friday, March 21, 2025, 12:00 Hrs [IST] ...
Pharmabiz20h
Novartis announces positive data from phase III study of intrathecal onasemnogene abeparvovec in broad patient population with SMA
Novartis announces positive data from phase III study of intrathecal onasemnogene abeparvovec in broad patient population with SMA: Basel Friday, March 21, 2025, 11:00 Hrs [IST] N ...
Pharmabiz21h
Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...